Previously, ATX-II was found to increase CYP 1 transcription and activity in oesophageal cancer cells starting at a concentration of 0.05 μM and 0.1 μM, respectively [51], indicating a higher sensitivity to AhR activation compared to the breast cancer cell line MCF-7. Here, AHR is linked to breast carcinoma.